Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Comprehensive Metabolic Panel (CMP) Testing Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The comprehensive metabolic panel (CMP) testing market has experienced substantial growth in recent years. It is forecast to expand from $17.04 billion in 2024 to $18.34 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.6%. The historical surge in this market can be attributed to several factors, including a rise in chronic diseases, the increasing demand for holistic health assessments, a greater emphasis on preventive care by healthcare systems, the emergence of lifestyle-related conditions, and the adoption of a patient-centric healthcare approach.
The comprehensive metabolic panel (cmp) testing market is projected to experience robust expansion over the coming years. This market is anticipated to reach $25.95 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the forecast period include the increasing adoption of personalized medicine and precision healthcare, the incorporation of CMP testing into telehealth services, a greater demand for thorough health screenings, an uptick in wellness and preventive health initiatives, and shifts in healthcare policies and regulations. Key trends expected in the forecast timeframe encompass continuous monitoring and longitudinal tracking, reporting formats suitable for telemedicine, the standardization of reference ranges, the integration of wearable health technology, and a stronger focus on patient education and engagement.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12362&type=smp
Which Drivers Are Shaping The Comprehensive Metabolic Panel (CMP) Testing Industry’s Market Share?
The projected expansion of the comprehensive metabolic panel (CMP) testing market is anticipated due to the rising incidence of cardiovascular diseases and diabetes. Cardiovascular disorders, which affect the heart or blood vessels, are associated with atherosclerosis, involving the accumulation of fatty deposits within arteries. Diabetes is a medical state characterized by excessively high blood glucose concentrations. Blood tests conducted as part of a comprehensive metabolic panel (CMP) measure glucose levels. Consequently, the growing number of diabetes and cardiovascular disease cases will necessitate diagnostic blood tests, including the CMP test, thereby fostering market development. For example, data from December 2023 released by the Australian Institute of Health and Welfare, an Australia-based national agency responsible for public health oversight, indicated 13,700 doctor-certified deaths due to CHD in 2020, rising to 14,100 in 2021, and further to 14,900 in 2022. Moreover, in June 2022, the International Diabetes Federation, a Belgium-based diabetes organization, reported that global diabetes prevalence had climbed to 10.5%, with more than half (44.7%) of affected individuals remaining undiagnosed. Hence, the escalating occurrence of cardiovascular diseases and diabetes is serving as a primary catalyst for the expansion of the comprehensive metabolic panel (CMP) testing market.
What Are The Key Segments In The Comprehensive Metabolic Panel (CMP) Testing Market?
The comprehensive metabolic panel (cmp) testingmarket covered in this report is segmented –
1) By Disease: Kidney Disease; Liver Disease; Diabetes; Other Diseases
2) By Test Type: Proteins; Electrolytes; Kidney Tests; Liver Functional Tests; Glucose
3) By End User: Laboratories; Point Of Care (PoC)
Subsegments:
1) By Kidney Disease: Chronic Kidney Disease (CKD); Acute Kidney Injury (AKI); Glomerulonephritis
2) By Liver Disease: Hepatitis (Viral And Non-Viral); Cirrhosis; Fatty Liver Disease
3) By Diabetes: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes
4) By Other Diseases: Cardiovascular Diseases; Electrolyte Imbalances; Metabolic Disorders; Pancreatic Diseases
Which Ongoing Trends Are Expected To Shape The Comprehensive Metabolic Panel (CMP) Testing Market Outlook?
The comprehensive metabolic panel (CMP) testing market is experiencing a significant surge in the adoption of technological advancements. Leading companies within the comprehensive metabolic panel (CMP) testing market are innovating new technologies to maintain their competitive edge. An illustrative example is HealthifyMe, an Indian wellness and fitness services company, which introduced its premier fitness plan, HealthifyPro, in April 2022. HealthifyPro’s metabolic panel relies on a blood test capable of assessing over 80 distinct indicators. Key elements incorporated into HealthifyPro for monitoring user health include a biosensor system (BIOS), a smart scale, dedicated health coaches, HealthifyMe’s artificial intelligence assistant, and a metabolic panel. This system consolidates information regarding glucose trends alongside users’ dietary intake and exercise habits to formulate a tailored strategy for every individual.
Who Are The Top Performing Companies In The Comprehensive Metabolic Panel (CMP) Testing Market In Recent Years?
Major companies operating in the comprehensive metabolic panel (CMP) testing market include Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC
Download The Full Report For Exclusive Market Findings:
What Are The Key Regional Factors Influencing The Comprehensive Metabolic Panel (CMP) Testing Market Growth?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (CMP) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Comprehensive Metabolic Panel (CMP) Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12362&type=smp
Browse Through More Reports Similar to the Global Comprehensive Metabolic Panel (CMP) Testing Market 2025, By The Business Research Company
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Blood And Blood Components Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report
Blood Collection Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model